Eli Lilly and Company (LLY) closed Wednesday, November 6, 2026, at $1,367.69 per share, a decline of 3.58% over the prior 24 hours. The single-session drop came despite broader momentum that has carried the stock significantly higher over the past month.
Over the trailing 30 days, LLY has gained 18.14%, reflecting sustained buying interest in the pharmaceutical giant. The seven-day change stands at -0.39%, suggesting the bulk of Wednesday's pullback represents a near-term reversal after a period of relative stability earlier in the week.
Eli Lilly's market capitalization stood at $1,263.07 billion as of Wednesday's close, keeping the company among the largest publicly traded firms by that measure. The session's decline trimmed that figure but left it broadly intact relative to the company's strong monthly performance.
Wednesday's move illustrates the volatility that can accompany high-priced, large-capitalization equities even during periods of overall strength. LLY's 30-day gain of 18.14% continues to represent a notable advance from levels seen a month prior.
